Duclauxin
Product Specifications
UNSPSC Description
Duclauxin decreases proliferation of tumor cells in vitro and increases the lifespan of mice innoculated with Ehrlich ascitic tumor cells. Duclauxin (10-30 μg/mL) inhibits mitochondrial respiration of P-388 tumor cells and nucleic acid synthesis in cell culture of Ehrlich cancer, the lymphadenomas NK/LI and L 5178, and sarcoma 37. Duclauxin also inhibits growth of wheat coleoptile.
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/duclauxin.html
Smiles
O=C1C2=C(O)C=C(C)C3=C2[C@]4([C@@]([C@]5(OC)[C@@]([C@H]4OC(C)=O)([H])C3=O)([H])C(C6=COC(C7=C(O)C=C(C)C5=C76)=O)=O)CO1
Molecular Weight
546.48
References & Citations
[1]Fusková, et al. In vitro effect of duclauxin and derivatives of coumarin on nucleic acid and protein synthesis in Ehrlich’s Ascites Carcinoma cells (EAC). Pharmazie 32(5), 291-293 (1977).
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-126617/Duclauxin-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-126617/
Clinical Information
No Development Reported
CAS Number
1732-37-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items